Evidence map›Paper›PMID 42783924›Full record

ReviewJournal of fungi (Basel, Switzerland)2026

Georgia Dimopoulou, Michael Papadoulakis, Ilias Premetis, Klairi Papachristou, Eleni E Magira

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Georgia DimopoulouFirst Department of Critical Care Medicine, Evangelismos General Hospital, Medical School, National and Kapodistrian University of Athens, 106 76 Athens, Greece.
Michael PapadoulakisFirst Department of Critical Care Medicine, Evangelismos General Hospital, Medical School, National and Kapodistrian University of Athens, 106 76 Athens, Greece.
Ilias PremetisFirst Department of Critical Care Medicine, Evangelismos General Hospital, Medical School, National and Kapodistrian University of Athens, 106 76 Athens, Greece.
Klairi PapachristouFirst Department of Critical Care Medicine, Evangelismos General Hospital, Medical School, National and Kapodistrian University of Athens, 106 76 Athens, Greece.
Eleni E MagiraFirst Department of Critical Care Medicine, Evangelismos General Hospital, Medical School, National and Kapodistrian University of Athens, 106 76 Athens, Greece.ORCID 0000-0002-4430-7886

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsWe conducted a narrative review of published studies evaluating

resultsColonization rates varied widely according to local epidemiology, ranging from 0.2 to 0.4% in routine surveillance studies to over 50% during outbreaks. Across 17 observational studies including 1879 colonized ICU patients, 616 developed invasive infection, yielding a descriptive pooled incidence of 32.8% (95% CI, 30.7-34.9%), predominantly candidemia. The median interval from ICU admission to candidemia was 25.8 days. Among 13 studies including 1354 colonized and/or infected ICU patients, the descriptive pooled 30-day in-hospital mortality was 36.4% (95% CI, 33.8-39.0%). In 12 studies comprising 396 patients with

conclusions

Indexed as

Candida auriscandidemia incidenceCandidozyma auriscolonization ratecritically ill patientsintensive care unitmortality

Identifiers

PMID42783924
PMCPMC13608876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.